Drug Name |
Doxazosin |
Drug ID |
BADD_D00718 |
Description |
Doxazosin is an alpha-1 antagonist used for the treatment of benign prostatic hypertrophy (BPH) symptoms and hypertension. Other members of this drug class include [Prazosin], [Terazosin], [Tamsulosin], and [Alfuzosin].[A180661] Because of its long-lasting effects, doxazosin can be administered once a day.[A180649] It is marketed by Pfizer and was initially approved by the FDA in 1990.[L7285] |
Indications and Usage |
For treatment and management of mild to moderate hypertension and urinary obstruction symptoms caused by BPH. |
Marketing Status |
Prescription; Discontinued |
ATC Code |
C02CA04 |
DrugBank ID |
DB00590
|
KEGG ID |
D07874
|
MeSH ID |
D017292
|
PubChem ID |
3157
|
TTD Drug ID |
D03MIR
|
NDC Product Code |
0049-2614; 23155-092; 68071-4272; 50090-3927; 42291-259; 70518-2183; 68071-4892; 16729-415; 68382-784; 68788-7149; 70518-1560; 50090-0704; 0049-2040; 70518-1804; 70934-362; 68071-5153; 16729-414; 65427-018; 71610-043; 66267-377; 50090-5773; 70771-1112; 50090-0734; 0904-5523; 16729-213; 60505-0093; 68788-7328; 60505-0094; 68084-862; 43063-739; 59762-2420; 16729-211; 71335-0309; 23155-095; 63629-7891; 68382-785; 59762-2410; 50090-2153; 59762-2480; 71610-628; 68084-836; 71335-0002; 55154-7996; 0049-2410; 70934-921; 71610-153; 50090-0701; 23155-094; 68071-3298; 42291-258; 70771-1113; 0049-2512; 0904-5522; 68084-851; 50090-4000; 50090-4004; 23155-093; 42291-260; 60505-0096; 68382-786; 0904-5524; 50090-5540; 60505-0095; 50090-0706; 50090-3987; 68071-4273; 72189-117; 71610-160; 70934-366; 68382-783; 70771-1114; 70771-1115 |
Synonyms |
Doxazosin | Novo-Doxazosin | Novo Doxazosin | Uriduct | Alfamedin | Apo-Doxazosin | Apo Doxazosin | Cardura | Cardular | Zoxan | Carduran | Carduran Neo | Neo, Carduran | Diblocin | Doxa-Puren | Doxa Puren | Doxacor | DoxaUro | Doxagamma | Doxamax | Doxatensa | Doxazomerck | Doxazosin AL | Doxazosin Apogepha | Doxazosin AZU | Doxazosin beta | Doxazosin findusFit | Doxazosin Heumann | Doxazosin Klast | Doxazosin Mesylate | Mesylate, Doxazosin | 1 (4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-((2,3-dihydro-1,4-benzodioxin-2-yl)carbonyl)piperazine | Doxazosin Monohydrochloride | Monohydrochloride, Doxazosin | Doxazosin Stada | Doxazosin Von Ct | Ct, Doxazosin Von | Von Ct, Doxazosin | Doxazosin-ratiopharm | Doxazosin ratiopharm | ratio-Doxazosin | ratio Doxazosin | Doxazosina Ratiopharm | Ratiopharm, Doxazosina | Doxazosin-Wolff | Doxazosin Wolff | Doxazosina Alter | Doxazosina Cinfa | Doxazosina Combino Pharm | Doxazosina Geminis | Doxazosina Normon | Doxazosina Pharmagenus | Doxazosina Ur | Gen-Doxazosin | Gen Doxazosin | Jutalar | MTW-Doxazosin | MTW Doxazosin | Progandol Neo | UK-33274 | UK 33274 | UK33274 |